Ropivacaine

( DrugBank: Ropivacaine / KEGG DRUG: Ropivacaine hydrochloride, Ropivacaine )

---

5 diseases

22. もやもや病

---

臨床試験数 : 23 / 薬物数 : 29 - (DrugBank : 21) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 50 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

36. 表皮水疱症

---

臨床試験数 : 183 / 薬物数 : 159 - (DrugBank : 51) / 標的遺伝子数 : 69 - 標的パスウェイ数 : 147 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

46. 悪性関節リウマチ

---

臨床試験数 : 4,543 / 薬物数 : 2,251 - (DrugBank : 390) / 標的遺伝子数 : 198 - 標的パスウェイ数 : 232 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

70. 広範脊柱管狭窄症

---

臨床試験数 : 127 / 薬物数 : 178 - (DrugBank : 67) / 標的遺伝子数 : 87 - 標的パスウェイ数 : 99 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

97. 潰瘍性大腸炎

---

臨床試験数 : 3,305 / 薬物数 : 1,646 - (DrugBank : 318) / 標的遺伝子数 : 165 - 標的パスウェイ数 : 220 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries